Literature DB >> 3142085

Diurnal variation of the fibrinolytic system.

V Grimaudo1, J Hauert, F Bachmann, E K Kruithof.   

Abstract

To elucidate which component(s) of the fibrinolytic system is (are) responsible for the diurnal variation of fibrinolytic activity we have studied several parameters of this system in 8 healthy male volunteers during a period of 24 h. Blood was collected at 8 a.m., 10 a.m., 12 a.m., 4 p.m., 8 p.m. and 8 a.m. next morning. The following tests were performed: euglobulin clot lysis time (ECLT), fibrinolytic activity of euglobulins on fibrin plates in the presence and absence of blocking antibodies to tissue-type plasminogen activator (t-PA) and/or urokinase (u-PA), overall plasminogen activator inhibitor (PAI) activity, antigen levels of t-PA, u-PA and PAI-1 and zymography of the euglobulin fraction after SDS-PAGE. From 8-10 a.m. to 4-8 p.m., total fibrinolytic activity increased by 113% (p less than 0.01) or 71% (p less than 0.01) when measured by ECLT or by fibrin plate assay, respectively. The immunoquenching experiments showed that this increase was entirely due to t-PA related activity whereas u-PA activity and t-PA/u-PA independent activity remained constant during the day. Average antigen levels of u-PA and t-PA in the afternoon were 6% and 25% lower than those measured in the morning. During this period, overall PAI activity and PAI-1 antigen decreased by 31% (p less than 0.01) and 52% (p less than 0.01) respectively. Electrophoretic-zymographic analysis of the euglobulins revealed that throughout the day the majority of t-PA was present in the form of the 110 kDa t-PA/PAI-1 complex. The intensity of this complex was lowest in the afternoon.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3142085

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  16 in total

1.  Antineoplastic agent busulfan regulates a network of genes related to coagulation and fibrinolysis.

Authors:  Janka Reimer; Sandra Bien; Sabine Ameling; Elke Hammer; Uwe Völker; Georg Hempel; Joachim Boos; Heyo K Kroemer; Christoph A Ritter
Journal:  Eur J Clin Pharmacol       Date:  2012-06       Impact factor: 2.953

2.  Effects of doxazosin and atenolol on the fibrinolytic system in patients with hypertension and elevated serum cholesterol.

Authors:  J H Jansson; B Johansson; K Boman; T K Nilsson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Influence of presentation at the weekend on treatment and outcome in ST-elevation myocardial infarction in hospitals with catheterization laboratories.

Authors:  Patricia Krüth; Uwe Zeymer; Anselm Gitt; Claus Jünger; Harm Wienbergen; Franz Niedermeier; Hans-Georg Glunz; Jochen Senges; Ralf Zahn
Journal:  Clin Res Cardiol       Date:  2008-05-08       Impact factor: 5.460

4.  Circadian variation in the effect of intravenous thrombolysis after non-lacunar stroke.

Authors:  Manuel Cappellari; Paolo Bovi; Giuseppe Moretto
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

5.  Circadian patterns of ST elevation myocardial infarction in the new millennium.

Authors:  Rajan Kanth; Sunitha Ittaman; Shereif Rezkalla
Journal:  Clin Med Res       Date:  2013-04-11

6.  Effects of isradipine sustained release on platelet function and fibrinolysis in essential hypertensives with or without other risk factors.

Authors:  G Ranieri; V Filitti; A Andriani; M V Bonfantino; G Lamontanara; A Cavallo; M Milani; R De Cesaris
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727

7.  Individual lytic efficacy of recombinant tissue plasminogen activator in an in vitro human clot model: rate of "nonresponse".

Authors:  Jason M Meunier; Evan Wenker; Christopher J Lindsell; George J Shaw
Journal:  Acad Emerg Med       Date:  2013-05       Impact factor: 3.451

8.  Different clinical presentations of a lupus anticoagulant in the same family.

Authors:  R M Jolidon; H Knecht; L Humair; A de Torrente
Journal:  Klin Wochenschr       Date:  1991-05-24

9.  Enalapril related changes in the fibrinolytic system in survivors of myocardial infarction.

Authors:  J H Jansson; K Boman; T K Nilsson
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Circadian pattern of acute variceal bleeding among cirrhotic Egyptian patients.

Authors:  Salah Aref; Ehab E Abdel-Khalek; Ibrahim A Abdel-Aal; Mohammed El Refaie
Journal:  Indian J Hematol Blood Transfus       Date:  2009-07-05       Impact factor: 0.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.